Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...

Model includes age, body mass index, hypertriglyceridemia, tumor staging, tumor grade, CA125 level, platelet count, fibrinogen level.

Ovarian cancer articles from across Nature Portfolio Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women ...

AbbVie hopes for another lift to its fast-growing ovarian cancer drug Elahere, with new survival data.

Experimental treatment could offer a safer, cheaper alternative to CAR-T-cell therapies for disorders such as lupus.